ACUTA CAPITAL PARTNERS, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,300,171
-65.7%
244,484
-17.8%
6.23%
-66.1%
Q2 2023$27,110,996
+41.5%
297,596
+2.4%
18.37%
+30.1%
Q1 2023$19,161,380
+70.4%
290,500
+33.6%
14.12%
+104.0%
Q4 2022$11,246,925
-70.3%
217,500
-60.7%
6.92%
-57.5%
Q3 2022$37,838,000
+51.0%
554,0000.0%16.29%
+16.7%
Q2 2022$25,052,000
-11.0%
554,0000.0%13.96%
+6.1%
Q1 2022$28,149,000
+11.3%
554,000
+3.6%
13.15%
+23.7%
Q4 2021$25,295,000
+916.7%
535,000
+608.6%
10.63%
+1110.9%
Q3 2021$2,488,000
-75.5%
75,500
-53.0%
0.88%
-78.3%
Q2 2021$10,144,000
+108.9%
160,500
+41.8%
4.05%
+131.5%
Q1 2021$4,856,000
-49.2%
113,161
-32.3%
1.75%
-32.7%
Q4 2020$9,555,000
+89.6%
167,0540.0%2.60%
+89.9%
Q3 2020$5,040,000
-18.8%
167,054
-12.1%
1.37%
-23.6%
Q2 2020$6,205,000
+10.5%
190,000
-9.3%
1.79%
-34.1%
Q1 2020$5,613,000
-2.2%
209,500
+11.7%
2.72%
+91.4%
Q4 2019$5,741,000
+55.3%
187,500
+11.6%
1.42%
+116.1%
Q2 2018$3,696,000168,0000.66%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders